Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Pharming Group ( (NL:PHARM) ) is now available.
Pharming Group announced its participation in two major investor conferences in April 2025, including the Van Lanschot Kempen Life Sciences Conference in Amsterdam and the 24th Annual Needham Virtual Healthcare Conference. This participation is expected to enhance Pharming’s visibility in the investor community and potentially strengthen its market position by showcasing its innovative biopharmaceutical developments.
More about Pharming Group
Pharming Group N.V. is a global biopharmaceutical company focused on transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes innovative medicines, including small molecules and biologics, and operates in over 30 markets across North America, Europe, the Middle East, Africa, and Asia-Pacific.
YTD Price Performance: -12.04%
Average Trading Volume: 16,956
Technical Sentiment Signal: Buy
Current Market Cap: $594.9M
See more data about PHARM stock on TipRanks’ Stock Analysis page.